Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title	Author(s)
	2025-06-03	Mekanisme neurotoksisiti methiopropamine (MPA) terhadap tingkah laku dan otak pada mencit	Norazrina binti Azmi, Prof. Madya. Dr.; Nor Syafinaz Yaakob, Dr.; Mohd Hanafi bin Ahmad Damanhuri, Prof. Madya. Dr.; Yow Hui Yin, Dr.; Mohd Khairulanwar Bunaim (P112632)
	2025-06-03	Penerokaan rawatan penyakit ringan dalam sistem kesihatan Malaysia: potensi pemerkasaan peranan ahli farmasi komuniti	Ernieda Md Hatah, Dr.; Mohd Makmor Bakry, Prof. Dr.; Tew, Mei Mei (P97783)
	2025-03-20	Development, validation and evaluation of an education tool for women with breast cancer on adjuvant endocrine therapy	Noraida Mohamed Shah, Assoc. Prof. Dr.; Ernieda Md Hatah, Assoc. Prof. Dr.; Nor Asyikin Mohd Tahir, Dr.; Nur Fa’izah Ab Muin, Dr.; Izzati Yussof (P110201)
	2025-01-06	Development and validation of an Interactive Education Tool (IET) on insulin therapy for children and adolescents with type 1 diabetes mellitus	Noraida Mohamed Shah, Dr.; Adyani Md Redzuan, Dr.; Siti Azdiah Abdul Aziz, Dr.; Sasha Mohamed Elamin Suliman Ali (P111692)
	2024-11-19	Penentuan fizikokimia dan aktiviti penyembuhan luka sistem gabungan pembawa lipid berstruktur nano -bigel yang dimuat dengan kurkumin untuk rawatan ulser tekanan	Mohd Hanif Zulfakar, Prof. Madya Dr.; Fazren Azmi, Prof. Madya Dr.; Nur Amira Mohd Shamsuddin (P111039)
	2025-03-19	The impact of pharmacogenetic polymorphisms in tacrolimus-based immunosuppressive therapy on clinical outcomes, expenditures and quality of life in kidney transplant recipients	Mohd Makmor-Bakry, Prof. Dr.; Nor Asyikin Mohd Tahir, Dr.; Wong Hin Seng, Dr.; Rosnawati Yahya, Dr.; Choong, Chiau Ling (P112748)
	2024-11-04	Medication administration errors in the Neonatal Intensive Care Unit: contributory factors, impact and risk prediction tool development	Noraida Mohamed Shah, Assoc. Prof. Dr.; Adliah Mhd Ali, Dr.; Nurul Ain Mohd Tahir, Dr.; Chandini Menon Premakumar, Dr.; Lim, Wern Han, Dr.; Josephine Henry Basil (P112701)
	2024-05-30	Developing and validating a pharmacist post-acute Covid-19 counseling tool	Farida Islahudin,Prof. Dr.; Mohd Bin Makmor Bakry, Prof. Dr.; Siti Azdiah Binti Abdul Aziz, Dr.; Ahtheemathurra Ballasingam (P112599)
	2024-03-13	Inisiatif penambahbaikan penyampaian perkhidmatan klinik kepatuhan terapi ubat-ubatan diabetes (diabetes medication therapy adherence clinic)	Ernieda Md. Hatah,Prof. Madya Dr.; Chong Wei Wen, Dr.; Adliah Mhd Ali, Dr.; Fahmi Hassan (P100391)
	2024-03-08	Development and implementation testing of a medication review service blueprint for community pharmacy practice in Malaysia	Ernieda Hatah, Assoc. Prof. Dr.; Mohd Makmor-Bakry, Prof. Dr.; Maali Mujahid Mustafa (P97973)
	2016-02-19	Imiquimod-loaded fish oil bigels and its effectiveness on treatment of non-melanoma skin cancer	Mohd Hanif Zulfakar, Dr.; Khurram Rehman (P68017)
	2016-08-15	Phytochemical study of selected ficus species (moraceae) and immunomodulatory, xanthine oxidase, soybean lipoxygenase inhibitory activities of their isolated compounds	Ibrahim Jantan, Prof. Dr.; Shukranul Mawa (P57661)
	2016-11-26	Immunosuppressive effects of standardised extracts of phyllanthus amarus, phyllanthus urinaria and their major compunds on cellular and humoral immune response	Ibrahim Jantan, Prof Dr.; Menaga D/O Ilangkovan (P63480)
	2015-02-17	Physico-chemical and biological characteristics of siRNA-and DsiNA-loaded polycationic nanoparticulate systems	Haliza Katas, Assoc Prof Dr.; Maria (P65168)
	2022-07-21	Synthesis of non-symmetrical curcumin derivatives as anti-cancer agents and adjuvant to paclitaxel chemoresistance on triple-negative breast cancer cells	Lam Kok Wai, Assoc. Prof. Dr.; Khor Poh Yen (P97782)
	2015-10-26	Inhibitory effects of phyllanthus amarus, phyllanthus urinaria, gynura segetum and gendarussa vulgaris on innate immune response	Ibrahim Jantan, Prof. Dr.; Yuandani (P63477)
	2022-08-20	Subcutaneous biologic therapy in inflammatory arthritis patients: development of adherence assessment tool based on the theoretical domain framework	Adyani Md Redzuan, Assoc. Prof. Dr.; Salmi Abdul Razak (P87777)
	2016-07-21	Pre-clinical safety evaluation, scaling up and human clinical safety and efficacy of co-loaded hydrocortisone-hydroxytyrosol chitosan nanoparticles for the treatment of atopic dermatitis.	Haliza Katas, Assoc. Prof. Dr.; Muhammad Irfan Siddique (P74208)
	2022-06-22	Evaluation of immunoglobulin therapy and population pharmacokinetic model development	Noraida Mohamed Shah, Assoc. Prof. Dr.; Lee Jian Lynn (P93201)
	2022-10-01	The development of best practice model for medication management in residential aged care facilities	Marhanis Salihah Omar, Dr.; Mariani Ahmad Nizaruddin (P86093)